Animal models for dissecting the pathogenic role of ACE2 in COVID-19, and for the evaluation of therapeutic strategies targeting to block ACE2 interaction with the S protein and inhibit the immune activation/cytokine storm for modulating severe COVID-19 are also sorely needed. The gene discussed is ACE2; the disease is COVID-19.